Global Biosimilar Drug Development: Any Chance for Consolidation after 15 Years of Positive Regulatory Experience?

Authors

DOI:

https://doi.org/10.33892/aph.2021.91.138-139

Keywords:

Biosimilar, comparability, regulatory framework, interchangeability, access

Published

2021-11-15

How to Cite

(1)
Holló, Z. Global Biosimilar Drug Development: Any Chance for Consolidation After 15 Years of Positive Regulatory Experience?. Acta Pharm Hung 2021, 91, 138-139.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License